RBC Capital lowered the firm’s price target on Chemours (CC) to $17 from $25 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Commodity Chemicals. Chlor-alkali prices appear to be improving in Q1 and Building & Construction demand could improve seasonally, but cold weather delayed the onset of construction season and caused some outages while Consumer demand remains subdued on inflation impacts, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Chemours price target lowered to $16 from $19 at Barclays
- Chemours Company: Undervalued Growth Potential Driven by TSS Segment and Market Opportunities
- Chemours upgraded to Outperform from Neutral at Mizuho
- Chemours and Energy Fuels partner to expand domestic mineral supply chain
- Energy Fuels, Chemours form rare earth and critical mineral supply chain pact